Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
View in:
PubMed
subject areas
Anti-Bacterial Agents
Humans
Idiopathic Pulmonary Fibrosis
Pseudomonas Infections
Pulmonary Fibrosis
authors with profiles
Ayodeji Adegunsoye